Articles published in Journal of Blood & Lymph have been cited by esteemed scholars and scientists all around the world.
Journal of Blood & Lymph has got h-index 10, which means every article in Journal of Blood & Lymph has got 10 average citations.
Following are the list of articles that have cited the articles published in Journal of Blood & Lymph.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
19 | 20 | 29 | 63 | 18 | 24 | 51 | 41 | 8 | 16 | 23 | 7 |
Research, Review articles and Editorials |
15 | 20 | 15 | 26 | 8 | 17 | 18 | 11 | 3 | 11 | 2 | 5 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 0 | 5 | 24 | 2 | 3 | 2 | 9 | 5 | 4 | 13 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
34 | 56 | 59 | 51 | 54 | 51 | 42 | 35 | 47 | 22 | 16 | 2 |
Journal total citations count | 443 |
Journal impact factor | 2.82 |
Journal 5 years impact factor | 1.51 |
Journal cite score | 1.79 |
Journal h-index | 10 |
Journal h-index since 2019 | 8 |
Hepatitis B Reactivation in Patients with Hematological and Solid Malignancies: A Retrospective Analysis of Single Center’s Experience |
|
Evaluation of the Renal Safety of Direct Acting Antivirals in Chronic Hepatitis C Patients |
|
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report |
|
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor |
|
Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment |
|
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System |
|
Impact of the Age of Transfused Red Blood Cells in the Trauma Population |
|
Clinical Illness and Outcomes in Patients with Severe Community-Acquired Pneumonia: A Prospective Study |
|
HFE protein impact on iron metabolism |
|
HFE protein impact on iron metabolism |
|
Two or Combined Procedures |
|
Gynecology |
|
Ovarian Tissue Vitrification for Fertility Preservation |
|
Why Doesn't Imatinib Cure Chronic Myeloid Leukemia? |
|
Toxicological Study of Hydroalcoholic Extract of Blepharis maderaspatensis (L.) Heyne ex Roth in Wistar Albino Rats |
|
Evaluation of In Vivo Toxicity of Dichloromethane: Methanolic Leaf Extracts of Prosopis juliflora in Female Wistar Albino Rats |
|
GC-MS profile and phytochemical analysis of methanol extract of Atalantia racemosa Wight ex Hook leaves |
|
Baccharoides lasiopus: Review of its Medicinal uses, Phytochemistry and Pharmacological Properties |
|
Hematological reference values and animal welfare parameters of BALB/C-FMABC (Mus musculus) inoculated with Ehrlich tumor kept in the vivarium at ABC Medical School |
|
Phytochemical Screening and Antibacteria/ Antifungi Activities of Root and Shoot Extracts of Euphorbia hirta (Asthma Weed) |
|
Journal of Blood & Lymph received 443 citations as per Google Scholar report